Page last updated: 2024-09-05

dofequidar and Carcinoma, Epidermoid

dofequidar has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nishimura, T; Tatsumi, M; Tsuruo, T	1

Other Studies

1 other study(ies) available for dofequidar and Carcinoma, Epidermoid

Article	Year
Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression; Genes, MDR; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tissue Distribution	2002

Article

Year

Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.

European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:3

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression; Genes, MDR; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tissue Distribution

2002